Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Bialystok – page 24

575 clinical trials in Bialystok, Poland across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Bialystok at a glance
575
clinical trials
  • Research sites9
Type of trial
Recruitment status
Quick filters

575 trials in Bialystok

Open in trial search

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Obesity+2

Not recruiting

Study of Retatrutide for Patients with Obesity, Overweight, and Chronic Low Back Pain

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ly3437943 Sodium
  • Sponsor:Eli Lilly & Co.

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Sjogren's syndrome

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Psoriatic arthropathy

Not recruiting

Study of sonelokimab and risankizumab in adults with psoriatic arthritis who did not respond well to previous TNF inhibitor treatment

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:MoonLake Immunotherapeutics AG

Asthma

Not recruiting

Study on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Rheumatoid arthritis

Not recruiting

Study on the Effectiveness and Safety of CT-P13 for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Folic Acid
  • Sponsor:Celltrion Inc.

Psoriatic arthropathy

Not recruiting

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Psoriasis

Not recruiting

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Neurodermatitis

Not recruiting

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Psoriasis

Not recruiting

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Alumis Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Bialystok

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on bladder cancer treatment using combination therapies, and innovative approaches for advanced breast cancer management. Research includes novel treatments for various solid tumors and gynecological malignancies.

  • Non-muscle invasive bladder cancer treatment
  • Advanced/metastatic breast cancer therapies
  • Gynecological tumor treatments

Investigations emphasize combination therapies and targeted treatment approaches.

02 Neurological & Mental Health

Clinical research targeting early Alzheimer's disease, exploring new treatments to slow disease progression and improve cognitive function.

  • Alzheimer's disease progression
  • Cognitive function assessment
  • Disease-modifying therapies

Focus on developing interventions for early-stage neurological conditions.

03 Inflammatory Conditions

Comprehensive studies on various inflammatory conditions including psoriatic arthritis, plaque psoriasis, and Crohn's disease. Research spans both biologic-naive and experienced patients.

  • Moderate to severe plaque psoriasis
  • Active psoriatic arthritis treatments
  • Chronic rhinosinusitis management

Evaluating novel therapeutic approaches for inflammatory disorders.

04 Metabolic & Cardiovascular Health

Studies addressing obesity, chronic kidney disease, and heart failure prevention. Research includes innovative treatments for weight management and cardiovascular risk reduction.

  • Obesity and weight management
  • Heart failure prevention
  • Chronic kidney disease treatments

Integration of multiple therapeutic approaches for complex metabolic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.